Status of work in September
In September, AOTMiT begins work on orders from the Minister of Health:
- Ibrance (palbociclib) + palbociclib in combination with fulvestrant in first-line treatment of breast cancer patients
- Keytruda (pembrolizumab) in the treatment of patients with hepatocellular carcinoma or bile duct cancer
- Opdivo (nivolumab) in the treatment of patients with colorectal cancer
- Yervoy (ipilimumab) for the treatment of patients with colorectal cancer
The listed order is available on the AOTMiT Public Information Bulletin.